Healthline
October 29, 2025
Share on PinterestA new study found that around 18% of UTIs are linked to contaminated meat. Maksymenko Nataliia/Getty Images A new study finds that nearly one-fifth […]
October 28, 2025
Share on PinterestA new study found that longer walks substantially lowered the risk of cardiovascular disease compared to shorter walks. Igor Alecsander/Getty Images A long walk […]
October 26, 2025
Share on PinterestNew research identified a 27% increased risk of metabolic syndrome among subjects experiencing early natural menopause. Nazar Rybak/Getty Images A study has found that […]
October 25, 2025
Share on PinterestThere may be fewer Medicare Advantage plans available in 2026, although the average premium is expected to decrease. Johner Images/Getty Images The Medicare open […]
Medscape
July 4, 2025
TOPLINE: An artificial intelligence (AI) model achieved a sensitivity of 91.8% in detecting pancreatic cancer on CT scans at diagnosis, with a 53.9% sensitivity for scans […]
July 4, 2025
TOPLINE: Augmenting antidepressant treatment with pramipexole led to a significant reduction in symptoms relative to placebo in treatment-resistant major depressive disorder (MDD) at 12 weeks, a […]
July 4, 2025
TOPLINE: Patients with sludge- or microlithiasis-induced acute pancreatitis (AP) had significantly lower rates of pancreaticobiliary complications than those with gallstone-induced AP. METHODOLOGY: Researchers enrolled 789 patients […]
July 4, 2025
Healthcare leaders have cautiously welcomed the government’s 10-year plan for the NHS in England, praising its ambitions while warning that workforce shortages and funding gaps could […]
FDA
November 19, 2025
Resources The innovative regulatory approaches resulting from the 21st Century Cures Act are modernizing new drug development. The use of clinical trials with Master Protocol design […]
November 19, 2025
HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]
November 19, 2025
On November 19, 2025, the Food and Drug Administration approved selumetinib (KOSELUGO, AstraZeneca Pharmaceuticals LP) for adults with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable […]
November 19, 2025
HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]
